SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Magellan Rx Management, the full-service pharmacy benefits management
division of Magellan
Health, Inc. (NASDAQ:MGLN), announced the launch of MRx Predict, a
new advanced analytics capability that proactively identifies patients
at-risk of experiencing adverse events, and forecasts future drug cost
drivers for customers.
People are also reading…
As drug costs continue to rise and create challenges for payers, there
is a need for a proactive approach to managing trend and spend while
maximizing the quality of healthcare for patients. MRx Predict offers
two forward-looking solutions designed to manage drug spend and improve
patient outcomes.
Drug Cost Forecasting provides macro predictions on drug spend
and trend, and the factors driving those future trends. This
capability allows customers to better plan for future drug
expenditures, and identify top therapeutic conditions and drugs,
including pipeline products, driving these costs.
At-Risk Patient Identification proactively identifies and
stratifies individual patients based on the probability of being
non-adherent to chronic medications, such as those for diabetes, high
blood pressure, and high cholesterol, along with specialty conditions
such as HIV/AIDS. It also recognizes patients that are at-risk for
misusing their opioid therapies. This helps improve patient outcomes
by optimizing our delivery of targeted clinical programs to those
patients most at-risk for adverse outcomes.
“MRx Predict identifies areas of opportunity for our customers to
improve the clinical outcomes of their patients and effectively plan for
future drug expenditures,” said Karim Prasla, vice president of clinical
outcomes, advanced analytics, and research for Magellan Rx Management.
“This capability provides our customers with key insights, leveraging
the latest analytics technology and domain expertise to generate
powerful results.”
To learn more about Magellan MRx Predict, view our webinar here.
Magellan Rx Management is a full-service, next generation PBM with a
value-driven approach that moves past the traditional volume-focused
thinking to deliver meaningful solutions. Magellan Rx Management
services expand beyond traditional core services to help their customers
and members solve complex pharmacy challenges by connecting them to the
people, technology and information they need to make smarter healthcare
decisions. As pioneers in managing specialty spend both on the
prescription and medical benefit, Magellan Rx Management is
effectively-positioned to continue delivering thought-leading solutions
in this complex and rapidly growing area of healthcare to help people
live healthier lives.
About Magellan Health: Magellan
Health, Inc., a Fortune
500 company, is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through technology,
while remaining focused on the critical personal relationships that are
necessary to achieve a healthy, vibrant life. Magellan's customers
include health plans and other managed care organizations, employers,
labor unions, various military and governmental agencies and third-party
administrators. For more information, visit MagellanHealth.com.
(MGLN-GEN)
Contacts
Magellan Health, Inc.
Media:
Lilly Ackley, 860-507-1923
or
Investors:
Joe
Bogdan, 860-507-1910